RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
At close: Oct 7, 2026
RGRX Market Cap
RGRX has a market cap or net worth of $1.66 thousand as of October 9, 2026. It is the 52,323rd most valuable company in the world and the 8,320th biggest in the United States. Its market cap has decreased by 99.32% in one year.
Market Cap
1.66K
Enterprise Value
n/a
Revenue
76.76K
Global Rank
Country Rank
#8,320 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 1987, RGRX's market cap has decreased from 58.65M to 1.66K, a decrease of -100.00%. That is a compound annual growth rate of -23.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.66K | 266.23% |
| Dec 31, 2025 | 453.00 | -78.55% |
| Dec 26, 2024 | 2.11K | 16.69% |
| Dec 29, 2023 | 1.81K | -99.99% |
| Dec 30, 2022 | 19.94M | -13.19% |
| Dec 31, 2021 | 22.97M | -61.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TetraLogic Pharmaceuticals | 2.43K |
| Innoveren Scientific | 2.40K |
| OncoVista Innovative Therapies | 2.36K |
| Lipella Pharmaceuticals | 2.31K |
| Suvanza Pharma, LLC | 2.24K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |